Wells Fargo’s Anterix ATEX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$225K Sell
5,903
-6,469
-52% -$205K ﹤0.01% 4636
2025
Q4
$270K Buy
12,372
+5,401
+77% +$112K ﹤0.01% 4897
2025
Q3
$150K Buy
6,971
+285
+4% +$6.39K ﹤0.01% 5091
2025
Q2
$171K Buy
6,686
+797
+14% +$23.3K ﹤0.01% 4860
2025
Q1
$216K Buy
5,889
+48
+0.8% +$1.65K ﹤0.01% 4654
2024
Q4
$179K Buy
5,841
+1,849
+46% +$61.5K ﹤0.01% 4863
2024
Q3
$150K Sell
3,992
-920
-19% -$35.5K ﹤0.01% 4764
2024
Q2
$194K Buy
4,912
+270
+6% +$8.74K ﹤0.01% 4528
2024
Q1
$156K Buy
4,642
+528
+13% +$17.8K ﹤0.01% 4624
2023
Q4
$137K Buy
4,114
+848
+26% +$27.4K ﹤0.01% 4709
2023
Q3
$102K Sell
3,266
-4,980
-60% -$157K ﹤0.01% 4765
2023
Q2
$261K Buy
8,246
+4,425
+116% +$143K ﹤0.01% 4413
2023
Q1
$126K Buy
3,821
+3,212
+527% +$105K ﹤0.01% 4696
2022
Q4
$19.6K Sell
609
-182
-23% -$6.2K ﹤0.01% 5272
2022
Q3
$28K Sell
791
-157
-17% -$6.52K ﹤0.01% 5221
2022
Q2
$39K Sell
948
-3,634
-79% -$176K ﹤0.01% 5138
2022
Q1
$266K Sell
4,582
-3,573
-44% -$195K ﹤0.01% 4819
2021
Q4
$480K Buy
8,155
+6,627
+434% +$402K ﹤0.01% 4693
2021
Q3
$92K Buy
1,528
+59
+4% +$3.46K ﹤0.01% 5418
2021
Q2
$88K Sell
1,469
-3,334
-69% -$167K ﹤0.01% 5338
2021
Q1
$227K Sell
4,803
-6,886
-59% -$283K ﹤0.01% 5094
2020
Q4
$440K Buy
11,689
+2,683
+30% +$88.4K ﹤0.01% 4605
2020
Q3
$295K Sell
9,006
-26,105
-74% -$1.11M ﹤0.01% 4724
2020
Q2
$1.59M Buy
35,111
+4,833
+16% +$247K ﹤0.01% 3443
2020
Q1
$1.38M Buy
30,278
+23,835
+370% +$1.08M ﹤0.01% 3303
2019
Q4
$279K Buy
6,443
+5
+0.1% +$204 ﹤0.01% 4769
2019
Q3
$233K Buy
6,438
+1,866
+41% +$78.7K ﹤0.01% 4864
2019
Q2
$215K Sell
4,572
-810
-15% -$34.2K ﹤0.01% 4937
2019
Q1
$189K Buy
5,382
+5
+0.1% +$197 ﹤0.01% 4857
2018
Q4
$201K Sell
5,377
-33
-0.6% -$1.29K ﹤0.01% 4898
2018
Q3
$183K Buy
5,410
+382
+8% +$11.2K ﹤0.01% 5051
2018
Q2
$125K Sell
5,028
-347
-6% -$9.67K ﹤0.01% 5274
2018
Q1
$160K Buy
5,375
+26
+0.5% +$870 ﹤0.01% 5090
2017
Q4
$172K Sell
5,349
-2,428
-31% -$78.1K ﹤0.01% 5034
2017
Q3
$232K Buy
7,777
+658
+9% +$18K ﹤0.01% 4849
2017
Q2
$166K Hold
7,119
﹤0.01% 4895
2017
Q1
$156K Hold
7,119
﹤0.01% 4957
2016
Q4
$161K Buy
7,119
+3,033
+74% +$73.2K ﹤0.01% 4881
2016
Q3
$94K Sell
4,086
-1,643
-29% -$36.7K ﹤0.01% 4951
2016
Q2
$122K Buy
5,729
+551
+11% +$17.4K ﹤0.01% 4697
2016
Q1
$178K Buy
5,178
+1,739
+51% +$46K ﹤0.01% 4471
2015
Q4
$95K Sell
3,439
-13
-0.4% -$356 ﹤0.01% 4940
2015
Q3
$103K Buy
3,452
+2,802
+431% +$91.7K ﹤0.01% 4861
2015
Q2
$27K Buy
+650
New +$30.7K ﹤0.01% 5499

Other funds holding ATEX

Wells Fargo's ATEX Position: Q1 2026 in Review

Wells Fargo reduced its Anterix (ATEX) stake by 52% in Q1 2026, selling an estimated $205K and leaving 5,903 shares worth $225K. The position accounts for ﹤0.01% of the portfolio, ranked #4636.

Wells Fargo first reported a position in ATEX in Q2 2015 and has held it in 44 quarters since. The position peaked at $1.59M in Q2 2020. 132 funds tracked by Wall St. Rank hold ATEX as of Q1 2026.

  • Wells Fargo held 5,903 shares of Anterix worth $225K as of Q1 2026.
  • Wells Fargo sold 6,469 Anterix shares in Q1 2026, an estimated $205K.
  • Anterix made up ﹤0.01% of Wells Fargo's portfolio in Q1 2026, its #4636 holding.
  • Wells Fargo first reported a position in Anterix in Q2 2015 and has held it in 44 quarters since.
  • Wells Fargo's Anterix position peaked at $1.59M in Q2 2020.
  • 132 funds tracked by Wall St. Rank held Anterix as of Q1 2026.

Based on Wells Fargo's 13F filing for Q1 2026, filed 11 May 2026.